HRSV F/Fusion glycoprotein F0
Antibody, InVivo Block/Neutralizing Antibody-HRSV F/Fusion glycoprotein F0 Antibody, InVivo Block/Neutralizing Antibody- 询价
- Biogradetech
- 美国
- BGT-ANT-37250
- 2025年07月09日
- Block,ELISA
- Human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
免疫原详情见datasheet，该抗体亚型为：IgG1, kappa
- 保存条件：
-2°C-8°C
- 保质期：
1年
- 库存：
100
- 供应商：
艾美捷科技
- 宿主：
Human
- 应用范围：
Block,ELISA
- 抗体英文名：
HRSV F/Fusion glycoprotein F0 Antibody, InVivo Block/Neutralizing Antibody
- 抗体名：
HRSV F/Fusion glycoprotein F0 Antibody, InVivo Block/Neutralizing Antibody
HRSV F/Fusion glycoprotein F0 Antibody, InVivo Block/Neutralizing Antibody，HRSV F/Fusion glycoprotein F0 Antibody, InVivo Block/Neutralizing Antibody，HRSV F/Fusion glycoprotein F0 Antibody, InVivo Block/Neutralizing Antibody,HRSV F/Fusion glycoprotein F0 Antibody, InVivo Block/Neutralizing Antibody
产品名称：HRSV F/Fusion glycoprotein F0 Antibody, InVivo Block/Neutralizing Antibody-HRSV F/Fusion glycoprotein F0 Antibody, InVivo Block/Neutralizing Antibody
产品货号：BGT-ANT-37250
产品规格：100ug#1mg
应用类型：Block,ELISA
蛋白别名：Fusion glycoprotein F0, Fusion glycoprotein F2, F2, p27, Intervening segment, Pep27, Peptide 27, Fusion glycoprotein F1, F1, F, Human respiratory syncytial virus A (strain A2)
HRSV F/Fusion glycoprotein F0 Antibody, InVivo Block/Neutralizing Antibody-HRSV F/Fusion glycoprotein F0 Antibody, InVivo Block/Neutralizing Antibody详情见产品datasheet
点击：HRSV F/Fusion glycoprotein F0 Antibody, InVivo Block/Neutralizing Antibody-HRSV F/Fusion glycoprotein F0 Antibody, InVivo Block/Neutralizing Antibody更多Biogradetech产品信息价格，货期，产品说明，百度搜“艾美捷科技”进入官网网站，查看具体产品且快速下单。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Expression, Glycosylation, and Modification of the Spike (S) Glycoprotein of SARS CoV
syndrome (SARS)-coronavirus (CoV) within the host cell, a T7/vaccinia virus-based expression system coupled to immunoprecipitation with anti-S antibodies was used to test and analyze different forms of the S glycoprotein. The state of maturity of the S
ELISA Procedure for Measuring Serum Antibody Titer
of an antibody is shown in Figure 22. The titer was estimated to be 1 in 2400. Figure 22. Antibody titer graph (X = dilution corresponding to Ab titer) Further Methods for Evaluating Anti-peptide Antibodies If the antibodies are to be used as a reagent
Notes on Making Rat x Y3 Monoclonal Antibody Producing Hybridomas
of one rat spleen (approx. 10**8 cells) together with 6 x 10**7 Y3/Ag1.2.3 per fusion (the other half of the spleen cells can be frozen as a backup in 90% FCS +10% DMS0). c) Try and keep all cells, PEG and medium components at 37 deg. C
技术资料暂无技术资料 索取技术资料
